<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.126096.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Comparison of BiP and HSP70i as markers of unfolded protein response (UPR) in segmental and nonsegmental vitiligo</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 2 approved with reservations]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Setyanto</surname>
                        <given-names>Boedhy</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-5181-0631</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Kalim</surname>
                        <given-names>Handono</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Poeranto</surname>
                        <given-names>Sri</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Widasmara</surname>
                        <given-names>Dhelya</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-7952-4357</uri>
                    <xref ref-type="aff" rid="a5">5</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Clinical Dermatology and Venereology, Kepanjen Kanjuruhan Hospital, Malang, East Java, Indonesia</aff>
                <aff id="a2">
                    <label>2</label>Doctoral Program in Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia</aff>
                <aff id="a3">
                    <label>3</label>Department of Internal Medicine, Faculty of Medicine, Dr Saiful Anwar General Hospital, Malang, East Java, 65112, Indonesia</aff>
                <aff id="a4">
                    <label>4</label>Clinical Parasitology Department, Dr Saiful Anwar General Hospital, Malang, East Java, 65112, Indonesia</aff>
                <aff id="a5">
                    <label>5</label>Department of Dermatology and Venereology, Dr Saiful Anwar General Hospital, Malang, East Java, 65112, Indonesia</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:boedhysetyanto@gmail.com">boedhysetyanto@gmail.com</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>28</day>
                <month>3</month>
                <year>2023</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2023</year>
            </pub-date>
            <volume>12</volume>
            <elocation-id>343</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>25</day>
                    <month>11</month>
                    <year>2022</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Setyanto B et al.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/12-343/pdf"/>
            <abstract>
                <p>
                    <bold>Background:</bold> Unfolded protein response (UPR) is a misfolded protein that occurs because oxidative stress disrupts cellular redox potential that extends to the endoplasmic reticulum (ER). Binding immunoglobulin protein (BiP) and inducible heat shock protein (HSP70i) as ER chaperons play critical roles in melanocyte apoptosis. Our study aims to compare BiP and HSP70i as markers of UPR in patients with segmental vitiligo (SV) and non-segmental vitiligo (NSV).</p>
                <p>
                    <bold>Methods:</bold> The subjects were composed of 64 patients diagnosed with vitiligo, of whom 33 had NSV and 31 had SV. Skin biopsy and immunofluorescence were performed. We used BiP and HSP70i as markers of UPR. Descriptive statistics were used to analyze the data.</p>
                <p>
                    <bold>Results:</bold> UPR-BiP expression and UPR-HSP70i in the SV group was 2.66 &#x00b1; 3.07 and 3.85 &#x00b1; 4.92, respectively, with a p-value of 0.001 (&lt;&#x03b1; = 0.05). In the NSV group UPR-BiP expression and UPR-HSP70i was 12.55 &#x00b1; 11.85 and 14.79&#x00a0;&#x00b1; 14.72 respectively, with a p-value of 0.001 (&lt;&#x03b1; = 0.05). UPR expression using the HSP70i marker in both NSV and SV groups was higher than it was using the BiP marker. The relationship between UPR-HSP70i expression and UPR-BiP expression in the SV and NSV group was significant (p &lt;0.05) and positive.</p>
                <p>
                    <bold>Conclusions</bold>: HSP70i is superior to BiP as a marker for expressing UPR.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>HSP701</kwd>
                <kwd>BiP</kwd>
                <kwd>segmental vitiligo</kwd>
                <kwd>non-segmental vitiligo</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>Skin depigmentation that occurs over time as a result of cutaneous melanocytes is a characteristic of vitiligo, where the classification of vitiligo is divided into segmental vitiligo (SV) and non-segmental vitiligo (NSV), as well as mixed and unclassified vitiligo.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup> Prevalence of the disease is 0.5&#x2013;2% of the worldwide population.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> In Indonesia, 187 of the 2700 patients who visited the outpatient Dermatology and Venereology clinic of Kepanjen Hospital in South Malang between 2015 and 2019 had vitiligo, amounting to a prevalence of 7%. The peak occurrence of vitiligo is usually between the first and third decade of life and it has a psychological impact on the sufferer, although vitiligo is non-life threatening.
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup> The diagnosis of vitiligo can be made from clinical examination and additional laboratory tests are usually needed only for confirmation.
                <sup>
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup>
            </p>
            <p>The pathogenesis of SV, including neuropeptide, somatic mosaicism, and microvascular skin horning, which eventually cause melanocyte damage, is better known than that of NSV.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup>
                <sup>&#x2013;</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup> Otherwise, NSV pathogenesis is still multifactorial and polygenic. The dominant factors in the NSV pathogenesis are oxidative stress and autoimmunity.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref9">9</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref10">10</xref>
                </sup> However, the mechanisms involved in the onset and progression of vitiligo remain unclear. Several previous studies have linked endoplasmic reticulum (ER) stress, which has a relationship with oxidative and immune stress in the pathogenesis of vitiligo.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup> Oxidative stress disrupts the cellular redox potential that extends to the ER, so that protein will fail to fold and its accumulation will activate a response called the unfolded protein response (UPR).
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup>
                <sup>&#x2013;</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref13">13</xref>
                </sup>
            </p>
            <p>Binding immunoglobulin protein (BiP), an ER chaperone in the accumulation of unfolded protein, preferentially binds to unfolded protein peptides and releases the ER stress sensor to enable its spontaneous dimerization and activation.
                <sup>
                    <xref ref-type="bibr" rid="ref14">14</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref15">15</xref>
                </sup> Inducible heat shock protein 70 (HSP70i) can also be secreted from the stressed live cells as a chaperone. Intracellular HSP70i will bind native protein in response to stress, to prevent misfolding dan cellular apoptosis. Some experimental animal models have confirmed the action and overexpression of HSP70i in progressive depigmentation.
                <sup>
                    <xref ref-type="bibr" rid="ref16">16</xref>
                </sup>
                <sup>&#x2013;</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref18">18</xref>
                </sup> Thus, the presence of UPR is related to the extent and severity of vitiligo because it will eventually cause damage to and destruction of melanocyte cells.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref9">9</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref10">10</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref19">19</xref>
                </sup> The progressive depigmentation of NSV and its unpredictable disease course makes it an important subject for research. Therefore, this study aims to compare BiP and HSP70i associated with melanocyte cell death in SV and NSV patients.</p>
        </sec>
        <sec id="sec2" sec-type="methods">
            <title>Methods</title>
            <p>This research has been declared to be ethically feasible by the Health Research Ethics Committee, Faculty of Medicine, Brawijaya University, dated July 28
                <sup>th</sup>, 2021, with approval number 218/EC/KEPK-S3/07/2021.</p>
            <sec id="sec3">
                <title>Subjects</title>
                <p>The subjects were composed of 64 patients diagnosed with vitiligo, who were split into two groups: 33 patients in the NSV group and 31 patients in the SV group. The diagnosis of vitiligo was established by anamnesis, clinical examination, and skin biopsy. Anamnesis identifies the presence of milky white patches. In terms of clinical examination, SV is acute and appears rapidly within a few weeks and stabilizes within 1&#x2013;2 years.
                    <sup>
                        <xref ref-type="bibr" rid="ref9">9</xref>
                    </sup> On the other hand, NSV is characterized by the expansion of lesions on both sides of the body, and the disease progression is chronic and lifelong. The skin biopsy identifies if there are melanocytes at the lesion area in the epidermis.
                    <sup>
                        <xref ref-type="bibr" rid="ref14">14</xref>
                    </sup>
                </p>
                <p>All the recruited patients had attended the outpatient Dermatology and Venereology clinic at Kanjuruan Kepanjen General Hospital, Malang, East Java during the period of August 2021 to January 2022. All patients&#x2019; vitiligo was established by anamnesis, clinical examination and skin biopsy. The patients had no prior keloid history and ranged in age from 18 and 60. Exclusion criteria included pregnant women and patients with diabetes mellitus, HIV, Cushing syndrome, active infection, trauma, and malignancy, as well as smokers and those with too much sun exposure. Subjects who met the criteria gave written informed consent as research subjects, and we recorded demographic history, clinical disease history, and family history of vitiligo.</p>
            </sec>
            <sec id="sec4">
                <title>Skin biopsy</title>
                <p>The expression of the UPR marker was observed by skin biopsy and then an immunofluorescence examination to identify expression of BiP and HSP70i. In this research, all samples were taken from skin biopsy in the perilesional zone. Skin biopsy was taken the following way. Perilesional vitiligo was disinfected with 70% alcohol, and 0.25 ml lidocaine was applied as local anesthesia to the area to be biopsied. In this area, skin biopsy was performed using the punch biopsy method with a diameter of 3 mm, and the skin tissue was included in an Eppendorf. After completion, the wound was cleaned with 0.9% NaCl solution, had topical fucidic acid applied, and was closed using sterile gauze. All skin biopsies were performed at the Dermatology and Venereology outpatient clinic at Kanjuruhan Kepanjen General Hospital, and the samples were given to the clinical pathology department, Faculty of Medicine, Universitas Brawijaya Malang, for further processing.</p>
                <p>The tissue was cut on a microtome (Leica RM2245) to a thickness of 2&#x2013;3 mm then given a code according to the researcher&#x2019;s gross code, with the aim that tissue samples were not exchanged between patients before the sample was inserted into a cassette. After that, it was processed with the Automatic Tissue Tex Processor (Thermo, STP 121-2977-1902) tool for 90 min, according to the standards of the Anatomical Pathology Laboratory of the Faculty of Medicine, Universitas Brawijaya Malang, until an alarm sounded completion. The process of blocking and cutting the tissue was performed, with the epidermis removed from the Tissue Tex Processor and the tissue blocked with paraffin according to the researcher&#x2019;s gross code. The tissue was cut with a microtome tool with a thickness of 3&#x2013;5 microns. Next came the deparaffination process in which the tissue was cut to a thickness of 3&#x2013;5 microns and placed into four tubes. These were put in an oven for 3 min at a temperature of 70&#x2013;80&#x00b0;C. The tissue was then placed into two tubes of xylol solution for 20 min each. After that, the tissue was put into four alcohol tubes, each for 3 min (hydration), and placed in running water for 15 min. The process and cutting of the skin biopsy tissue with a microtome and hematoxylin eosin (HE) staining was carried out at the Anatomical Pathology Laboratory. All slides were viewed using an Olympus IX71 fluorescence microscope under 40&#x00d7; magnification.</p>
            </sec>
            <sec id="sec5">
                <title>Immunofluorescence &#x2013; BiP</title>
                <p>All slides that had been prepared were then stained with the direct immunofluorescence process. The staining process for BiP used the anti-BiP antibody kit (Abcam, rabbit polyclonal to GRP78 BiP, concentration &#x03bc;g at 1 mg/ml, catalog number Ab21685). Immunofluoresence processes were conducted in the biomedical laboratory at the Faculty of Medicine, Universitas Brawijaya. The slides were heated at 60&#x00b0;C for 60 min. Then the slides were immersed in the following solutions in sequence: first they were soaked in xylol solution for 2 &#x00d7; 10 min, then the slide was put into absolute ethanol for 2 &#x00d7; 10 min, then 90% ethanol for 1 &#x00d7; 5 min, then 80% ethanol for 1 &#x00d7; 5 min, then 70% ethanol for 1 &#x00d7; 5 min, and a last soak in the sterile Aquadest for 3 &#x00d7; 5 min.</p>
                <p>The antigen retrieval process was carried out with citrate buffer. In the first step, the slide was immersed in a chamber containing citrate buffer at pH 6.0. Then the slide was placed in a water bath at 95
                    <sup>o</sup>C for 20 mins. The slide was removed from the water bath after 20 mins, then allowed to cool to room temperature for about 20 mins. The slides were then cleaned three times for five mins with phosphate-buffered saline (PBS). The slides were then washed five times for one min with PBS Triton-X 100 0.2% (Sigma-Aldrich). The slide was incubated for 30 mins at room temperature with 3% Bovine Serum Albumin (BSA) andthe BSA solution was discarded. Subsequently, the slide with BiP antibody was incubated for an overnight period at 4&#x00b0;C. The slides with PBS were washed three times for 5 mins after an overnight incubation. Then the slide was incubated with 4&#x2019;,6-diamidino-2-phenylindole (DAPI) staining solution (Abcam) 1:1000 for 5 mins. Next, the slides were washed with PBS for 3 x 5 mins. The slides were then closed with mounting medium and a cover glass. An immunofluorescence microscope (Olympus IX71 fluorescence microscope under 40&#x00d7; magnification) was used to view and document the expression of BiP. The next process was to analyze expression using 
                    <ext-link ext-link-type="uri" xlink:href="http://imagej.nih.gov/ij">ImageJ</ext-link> software version 1.53k (Wayne Rasband and contributors, National Institutes of Health, USA; RRID:SCR_003070), and the results were compared.</p>
            </sec>
            <sec id="sec6">
                <title>Immunofluorescence &#x2013; HSP70i</title>
                <p>The staining process for HSP70 used anti-HSP70i antibody kit (Santa Cruz, catalog number Sc-32239, mouse monoclonal IgG1 &#x03ba; HSP70 antibody, with concentration 200 &#x03bc;g/ml). Immunofluoresence processes were conducted in the biomedical laboratory at the Faculty of Medicine, Universitas Brawijaya. The slides were heated at 60&#x00b0;C for 60 min. Then the slides were immersed in the following solutions in sequence: first they were soaked in xylol solution for two &#x00d7; 10 min, then the slides were put into absolute ethanol for two &#x00d7; 10 min, then 90% ethanol for one &#x00d7; 5 min, then 80% ethanol for one &#x00d7; 5 min, then 70% ethanol for one &#x00d7; 5 min, and the last soak was in sterile Aquadest for three &#x00d7; 5 min.</p>
                <p>Furthermore, the antigen retrieval process was carried out with citrate buffer. The first step involved immersing the slides in a chamber containing citrate buffer at pH 6.0. Then the slides were placed in a water bath at 95
                    <sup>o</sup>C for 20 mins. The slides were removed from the water bath after 20 mins, then allowed to cool to room temperature for 20 mins. The slides were then cleaned three times for five mins with PBS. They were then washed five times for one min with PBS Triton-X 100 0.2%. The slides were then incubated for 30 mins at room temperature with 3% Bovine Serum Albumin (BSA) and the BSA solution was then discarded. The slides were then incubated with the HSP antibody for an overnight period at 4&#x00b0;C. The slides were washed with PBS three times in five mins after the overnight incubation. Then the slide was incubated with DAPI 1:1000 for 5 mins. Next, the slides were washed with PBS for 3 x 5 mins. Then the slides were closed with mounting medium and cover glass. An immunofluorescence microscope was used to view and document the expression of BiP. The next process was to analyze expression using ImageJ software, and the results were compared.</p>
            </sec>
            <sec id="sec7">
                <title>Statistical analyses</title>
                <p>All research data processing techniques were analyzed using the Statistical Product and Service Solution software, IBM 
                    <ext-link ext-link-type="uri" xlink:href="https://www.ibm.com/products/spss-statistics">SPSS</ext-link> Statistics 20 (RRID:SCR_019096). Descriptive statistics were used to examine the data and determine percentages, mean values, and standard deviation. We used the non-parametric Mann-Whitney U test since the data were not regularly distributed. To examine the variance between the two groups, the student&#x2019;s t-test was used. Statistical significance was defined as a p-value 0.05.</p>
            </sec>
        </sec>
        <sec id="sec8" sec-type="results">
            <title>Results</title>
            <sec id="sec9">
                <title>Subject characteristics</title>
                <p>This study was composed of 64 vitiligo patients, of whom 33 had NSV and 31 had SV. The mean age was 22.32 &#x00b1; 9.20 years in the SV group and 44.79 &#x00b1; 11.24 years in the NSV group. 
                    <xref ref-type="table" rid="T1">Table 1</xref> lists the characteristics of the subjects.
                    <sup>
                        <xref ref-type="bibr" rid="ref15">15</xref>
                    </sup>
                </p>
                <table-wrap id="T1" orientation="portrait" position="float">
                    <label>Table 1. </label>
                    <caption>
                        <title>Characteristics of the study subjects&#x2019; clinical and demographic data.
                            <sup>
                                <xref ref-type="bibr" rid="ref15">15</xref>
                            </sup>
                        </title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Characteristic</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Non-segmental vitiligo</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Segmental vitiligo</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Age (Year)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">44.79 &#x00b1; 11.24</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">22.32 &#x00b1; 9.20</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Sex</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Female</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">20 (31.25%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">15 (23.44%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Male</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">13 (20.31%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">16 (25.00%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Family history of autoimmune disease</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Yes</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">13 (39.4%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">1 (3.33%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">No</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">20 (60.6%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">30 (96.7%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Duration of the disease (months)</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">&lt;6</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">2 (6.1%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">1 (3.2%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">6&#x2013;12</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4 (12.1%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">5 (16.1%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">&gt;12</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">27(81.8%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">25(80.7%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Marital status</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Married</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">29 (87.9%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">6 (19.4%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Unmarried</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4 (12.1%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">25 (80.6%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Social life</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Good</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">33 (100%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">31 (100%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Poor</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0 (0%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0 (0%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">History of therapy</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Corticosteroid topical</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">32 (97%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">17 (54.8%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">1 (3%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">7 (22.6%)</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">No therapy</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0 (0%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">7 (22.6%)</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
            </sec>
            <sec id="sec10">
                <title>HSP70i and BiP expression in patients with NSV and SV</title>
                <p>Median UPR-HSP70i and UPR-BiP expression in the NSV group was found to be 14.79 &#x00b1; 14.72 and 12.55 &#x00b1; 11.85 respectively, with a p-value of 0.001 (&lt;&#x03b1; = 0.05). Thus, it can be stated that there were differences in UPR expression when using the HSP70i and BiP markers in NSV patients. UPR expression using the HSP70i marker was higher compared with the BiP marker in the NSV group. For the SV group, we found the median UPR-HSP70i and UPR-BiP expression to be 3.85 &#x00b1; 4.92 and 2.66 &#x00b1; 3.07 respectively.
                    <sup>
                        <xref ref-type="bibr" rid="ref15">15</xref>
                    </sup> Graphics of median UPR-BiP expression in NSV and SV, as well as fluorescence of UPR-BiP expression in NSV and SV are shown in 
                    <xref ref-type="fig" rid="f1">Figure 1</xref>. Graphics of median UPR-HSP70i expression in NSV and SV, as well as fluorescence of UPR-HSP70i expression in NSV and SV are shown in 
                    <xref ref-type="fig" rid="f2">Figure 2</xref>.</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>(a) Median BiP is relatively higher in NSV than in SV. Under the Olympus IX71 fluorescence microscope at 40&#x00d7; magnification: (b) expression of BiP in NSV; (c) expression of BiP in SV.</title>
                        <p>
                            <sup>
                                <xref ref-type="bibr" rid="ref15">15</xref>
                            </sup>
                        </p>
                    </caption>
                    <graphic id="gr1" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/138473/1862fcbb-7b14-49b9-9ef9-b926b9a9ab3b_figure1.gif"/>
                </fig>
                <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                    <label>Figure 2. </label>
                    <caption>
                        <title>(a) Median HSP70i is relative higher in NSV than in SV. Under the Olympus IX71 fluorescence microscope at 40&#x00d7; magnification: (b) expression of HSP70i in NSV; (c) expression of HSP70i in SV.</title>
                        <p>
                            <sup>
                                <xref ref-type="bibr" rid="ref15">15</xref>
                            </sup>
                        </p>
                    </caption>
                    <graphic id="gr2" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/138473/1862fcbb-7b14-49b9-9ef9-b926b9a9ab3b_figure2.gif"/>
                </fig>
                <p>Mean UPR-HSP70i and UPR-BiP expression in the NSV group was found to be 14.79 &#x00b1; 14.72 and 12.55 &#x00b1; 11.85 respectively, with a 
                    <italic toggle="yes">p</italic>-value of 0.001 (&lt;&#x03b1; = 0.05). Thus, it can be stated that there were differences in UPR expression when using the HSP70i and BiP markers in NSV patients. UPR expression using the HSP70i marker was higher compared with the BiP marker in the NSV group. In the SV group, median UPR-HSP70i and UPR-BiP expression were found to be 3.85 &#x00b1; 4.92 and 2.66 &#x00b1; 3.07, respectively, with a 
                    <italic toggle="yes">p</italic>-value of 0.001 (&lt;&#x03b1; = 0.05). Thus, it might be concluded that there were differences in UPR expression when using the HSP70i and BiP markers in SV patients.
                    <sup>
                        <xref ref-type="bibr" rid="ref15">15</xref>
                    </sup>
                </p>
            </sec>
        </sec>
        <sec id="sec11" sec-type="discussion">
            <title>Discussion</title>
            <p>The ER in eukaryotic cells has an important role in synthesis, maturing protein, lipid metabolism, and intracellular calcium homeostasis.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref12">12</xref>
                </sup> Physiologically, the ER ensures that proteins are folded, always oxidized around the folds, and filled with calcium. Subtoxic levels of ER-stress-induced UPR in the skin are required for normal cellular function, including differentiation.
                <sup>
                    <xref ref-type="bibr" rid="ref16">16</xref>
                </sup> Melanocyte are more susceptible to oxidative stress in patients with vitiligo than in healthy individuals and melanocytes release reactive oxygen species (ROS) as a respond to stress.
                <sup>
                    <xref ref-type="bibr" rid="ref20">20</xref>
                </sup> The over-production of ROS and it's accumulation triggers protein oxidation and fragmentation, lipid peroxidation, and DNA damage, which compromises cellular function.
                <sup>
                    <xref ref-type="bibr" rid="ref10">10</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref21">21</xref>
                </sup> In addition, ROS also interfere with the work of the folding machinery of the ER, resulting in UPR.
                <sup>
                    <xref ref-type="bibr" rid="ref10">10</xref>
                </sup> This situation leads to chronic and continual ER stress that induces UPR, which has a deleterious effect on cells, and the UPR in turn becomes mechanism of a cell death.
                <sup>
                    <xref ref-type="bibr" rid="ref15">15</xref>
                </sup> The accumulation of UPR also disturbs transcription, translation, and mRNA translation in protein synthesis.
                <sup>
                    <xref ref-type="bibr" rid="ref22">22</xref>
                </sup>
                <sup>&#x2013;</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref24">24</xref>
                </sup>
            </p>
            <p>The ER stress response or the so-called UPR has been widely recognized in autoimmune and inflammatory diseases, where the UPR contributes to the course of autoimmune disease through the formation of antigens during the degradation of misfolded proteins, secreting neo-antigens by apoptotic cells or impairing immune tolerance.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref25">25</xref>
                </sup> The UPR can also be activated through an increase in unfolded protein that occurs as a result of the production of large amounts of protein during melanin synthesis.
                <sup>
                    <xref ref-type="bibr" rid="ref10">10</xref>
                </sup> Intracellular oxidative emphasise that outcomes from outside shows vulnerability to chemicals and harsh environmental factors, besides failure of the intracellular systems to overcome stress, and induces targeted melanocytic destruction.
                <sup>
                    <xref ref-type="bibr" rid="ref26">26</xref>
                </sup> Production of pro-inflammatory cytokines and signals that activate the innate immune system result from the ROS- and UPR-mediated death of keratinocytes and melanocytes. Then, pattern recognition receptors (PRR) and nucleic acid receptors through danger-associated molecular patterns (DAMP) recognize host-derived self-DNA/RNA from damaged cells.
                <sup>
                    <xref ref-type="bibr" rid="ref27">27</xref>
                </sup>
            </p>
            <p>The three ER transmembrane sensor proteins control UPR, namely inositol-requiring enzyme 1 alpha (IRE1a), double-stranded RNA-dependent protein kinase-like ER kinase (PERK) and activating transcription factor (ATF) 6.
                <sup>
                    <xref ref-type="bibr" rid="ref16">16</xref>
                </sup> All three sensors are primarily bound with BiP, which helps to maintain their inactive state, in non-stress conditions. The interplay between these three major arms of the UPR signaling pathways determines whether stressed cells survive or die.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup> The protein is known as a binding immunoglobulin protein because it is found in the ER and is bound to secreted Ig heavy chains.
                <sup>
                    <xref ref-type="bibr" rid="ref28">28</xref>
                </sup> The UPR pathway is activated when the calcium concentration in the ER is reduced, which causes a rapid buildup of unfolded/misfolded proteins and the promotion of dissociated BiP from three ER transmembrane sensor proteins: IRE1a, PERK, and ATF6.
                <sup>
                    <xref ref-type="bibr" rid="ref16">16</xref>
                </sup> In addition, BiP/GRP78 levels are very high in various human cancers.
                <sup>
                    <xref ref-type="bibr" rid="ref29">29</xref>
                </sup>
            </p>
            <p>In response to cellular stress and UPR activation, melanocytes secrete HSP70i, as many other cells do.
                <sup>
                    <xref ref-type="bibr" rid="ref27">27</xref>
                </sup> HSP70i binds native proteins to prevent misfolding and cellular apoptosis. In experimental animal models, the role of HSP70i overexpression in gradual depigmentation has been demonstrated.
                <sup>
                    <xref ref-type="bibr" rid="ref24">24</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref30">30</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref31">31</xref>
                </sup> The effector T cells are attracted to the dendritic cells by increasing signaling, which is induced by HSP70i.
                <sup>
                    <xref ref-type="bibr" rid="ref27">27</xref>
                </sup> Under stress, DAMPs that convey danger signals cause the innate immune system to become more activated by way of pattern recognition receptors (PRR) that include TLRs, RIG-I similar receptors, and NLRs. By producing cytokines, chemokines, and antigen-presenting molecules, this mechanism has the potential to both negatively destroy melanocytes and spark adaptive immunity.
                <sup>
                    <xref ref-type="bibr" rid="ref18">18</xref>
                </sup> Furthermore, it activates dendritic cells, and the activated DAMP and CD8
                <sup>+</sup> T cells stimulate the immune response to again destroy melanocytes.
                <sup>
                    <xref ref-type="bibr" rid="ref27">27</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref32">32</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref33">33</xref>
                </sup> Melanocyte-specific, cytotoxic CD8+ T lymphocytes are crucial for the melanocyte&#x2019;s eventual targeted demise.
                <sup>
                    <xref ref-type="bibr" rid="ref34">34</xref>
                </sup>
                <sup>&#x2013;</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref36">36</xref>
                </sup> It has been found that the severity of vitiligo disease is related to the intensity of the CD8+ reaction.
                <sup>
                    <xref ref-type="bibr" rid="ref25">25</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref37">37</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref38">38</xref>
                </sup>
            </p>
            <p>In our study, HSP70i and BiP expression were found to be relatively higher in NSV than in SV, indicating a higher response to oxidative stress that can interfere with transcription, translation, and translation of mRNA in protein synthesis, which is related to the extent and severity of vitiligo in NSV. Thus, dissimilar to SV, melanocyte destruction in NSV is mediated over diverse, intricate, and interconnected mechanisms.
                <sup>
                    <xref ref-type="bibr" rid="ref26">26</xref>
                </sup>
            </p>
            <p>Our study showed that expression using HSP70i was higher than with BiP, both in SV and NSV. Stressed vitiligo melanocytes secrete HSP70i that induce dendritic cells to increase the expression of CD80 and CD86, that stimulate immune responses to melanocytes. In a previous study using a mouse model, adding HSP70i alone could worsen vitiligo, perhaps causing over activation of dendritic cells in the skin. Meanwhile, in a mouse model lacking HSP70i expression, there was no depigmentation in the experimental study, which indicates the role of HSP70i in vitiligo. These dendritic cells can be stimulated to express more coactivation markers like CD80 and CD86, which will amplify the immune response against melanocytes.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup> As a result, HSP70i, which is overexpressed in lesional vitiligo epidermis compared to normal skin, might cause an autoimmune reaction in response to environmental stressors such oxidative stresses.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref35">35</xref>
                </sup> Thus, HSP70i is preferred because it can serve as a link between the innate and adaptive immune systems.
                <sup>
                    <xref ref-type="bibr" rid="ref27">27</xref>
                </sup>
            </p>
            <p>The existence of this UPR is seen as crucial because if it is not immediately addressed, it will disrupt homeostasis and protein, lipid, and DNA synthesis, which will then activate the apoptotic signaling pathway, resulting in melanocyte apoptosis. Furthermore, the apoptosis produces neo antigens that will stimulate the immune system.
                <sup>
                    <xref ref-type="bibr" rid="ref14">14</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref16">16</xref>
                </sup> Melanocyte apoptosis is a programmed cell death mechanism involving endonuclease enzymes, characterized by shriveled melanocyte cells that have the characteristic pattern of a step ladder and eventually become fragmented and release apoptosis bodies.
                <sup>
                    <xref ref-type="bibr" rid="ref38">38</xref>
                </sup> Precisely, CD8
                <sup>+</sup> T lymphocytes play a variety of roles in mediating melanocyte death.
                <sup>
                    <xref ref-type="bibr" rid="ref39">39</xref>
                </sup> The majority of melanocyte death is caused by immune cells breaching the self-tolerance as a result of melanocyte apoptosis, antigen exposure, and an inflammatory microenvironment.
                <sup>
                    <xref ref-type="bibr" rid="ref18">18</xref>
                </sup> In our investigation, the SV group had a relatively lower expression of melanocyte cell apoptosis than the NSV group. Although both SV and NSV exhibit melanocyte damage, it is unknown whether the loss of melanocytes in SV is brought on by an autoimmune reaction or a cellular defect that is already present.
                <sup>
                    <xref ref-type="bibr" rid="ref18">18</xref>
                </sup> However, our study is consistent with other studies showing an elevated anti-melanocyte antibody titer in NSV patients. This can be used as an important basis in the vitiligo pathogenesis.
                <sup>
                    <xref ref-type="bibr" rid="ref40">40</xref>
                </sup>
            </p>
        </sec>
        <sec id="sec12" sec-type="conclusions">
            <title>Conclusions</title>
            <p>In conclusion, the appearance of UPR and oxidative stress affect the progression of vitiligo, especially in NSV. Both HSP70i and BiP expression can be UPR markers, although HSP70i is superior in expressing UPR, compared with BiP, because it represents a link between the adaptive and innate immune systems; thus, HSP70i is recommended for use in future studies. The existence of this UPR is crucial because it can activate the apoptotic signaling pathway resulting in melanocyte apoptosis. Additional studies are necessary to investigate if UPR can be used as a new target in the treatment of vitiligo.</p>
        </sec>
        <sec id="sec13">
            <title>Consent</title>
            <p>Written informed consent for publication of their clinical details and clinical images was obtained from the patients.</p>
        </sec>
    </body>
    <back>
        <sec id="sec16" sec-type="data-availability">
            <title>Data availability</title>
            <sec id="sec17">
                <title>Underlying data</title>
                <p>Zenodo: Underlying data for &#x2018;Comparison of BiP and HSP70i as markers of unfolded protein response (UPR) in segmental and nonsegmental vitiligo&#x2019;. 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.7228247">https://doi.org/10.5281/zenodo.7228247</ext-link>.
                    <sup>

                        <xref ref-type="bibr" rid="ref15">15</xref>
</sup>
                </p>
                <p>This project contains the following underlying data:
                    <list list-type="bullet">
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Data file 1: Data and Demographic Journal 2.xlsx [demographic data of subjects]</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Data file 2: Journal 2-Statistical Data.docx [analysis data results]</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Data file 3: UPR expression of HSP70i and BiP.docx [Figure of UPR expression]</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 1: Ethical Approval Letter.pdf</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 2: BiP-NSV.jpeg</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 3: BiP-SV.png</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 4: DAPI BiP in NSV.jpg</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 5: DAPI BiP in SV.jpg</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 6: DAPI HSP70i NSV.jpg</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 7: DAPI HSP70i SV.jpg</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 8: HSP70i-NSV.png</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 9: HSP70i-SV.png</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 10: DAPI only (BiP NSV).jpg</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 11: DAPI only (BiP SV).jpg</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 12: DAPI only (HSP70i NSV).jpg</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Supplementary file 13: DAPI only (HSP70i SV).jpg
</p>
                        </list-item>
                    </list>
                </p>
                <p>Data are available under the terms of the 
                    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link> (CC-BY 4.0)</p>
            </sec>
        </sec>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Boniface</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Seneschal</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Picardo</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy.</article-title>
                    <source>

                        <italic toggle="yes">Clin. Rev. Allergy Immunol.</italic>
</source>
                    <year>2018</year>;<volume>54</volume>(<issue>1</issue>):<fpage>52</fpage>&#x2013;<lpage>67</lpage>.
                    <pub-id pub-id-type="pmid">28685247</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s12016-017-8622-7</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Habib</surname>
                            <given-names>A</given-names>
                        </name>
</person-group>:
                    <article-title>Clinical profile of segmental vitiligo in a group of Pakistani.</article-title>
                    <source>

                        <italic toggle="yes">Pak. Armed Forces Med. J.</italic>
</source>
                    <year>2019</year>;<volume>69</volume>(<issue>3</issue>):<fpage>495</fpage>&#x2013;<lpage>499</lpage>.</mixed-citation>
            </ref>
            <ref id="ref3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Karagaiah</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Schwartz</surname>
                            <given-names>RA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lotti</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Biologic and targeted therapeutics in vitiligo.</article-title>
                    <source>

                        <italic toggle="yes">J. Cosmet. Dermatol.</italic>
</source>
                    <year>2022</year>.
                    <pub-id pub-id-type="pmid">35029034</pub-id>
                    <pub-id pub-id-type="doi">10.1111/jocd.14770</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Faraj</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kemp</surname>
                            <given-names>EH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gawkrodger</surname>
                            <given-names>DJ</given-names>
                        </name>
</person-group>:
                    <article-title>Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors.</article-title>
                    <source>

                        <italic toggle="yes">Clin. Exp. Immunol.</italic>
</source>
                    <year>2022</year>;<volume>207</volume>(<issue>1</issue>):<fpage>27</fpage>&#x2013;<lpage>43</lpage>.
                    <pub-id pub-id-type="pmid">35020865</pub-id>
                    <pub-id pub-id-type="doi">10.1093/cei/uxab002</pub-id>
                    <pub-id pub-id-type="pmcid">PMC8802175</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Thakur</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bishnoi</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vinay</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Vitiligo: translational research and effective therapeutic strategies.</article-title>
                    <source>

                        <italic toggle="yes">Pigment Cell Melanoma Res.</italic>
</source>
                    <year>2021</year>;<volume>34</volume>(<issue>4</issue>):<fpage>814</fpage>&#x2013;<lpage>826</lpage>.
                    <pub-id pub-id-type="pmid">33756039</pub-id>
                    <pub-id pub-id-type="doi">10.1111/pcmr.12974</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Van Geel</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Van Haverbeke</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Speeckaert</surname>
                            <given-names>R</given-names>
                        </name>
</person-group>:
                    <article-title>Pathofisiology of segmental vitiligo.</article-title>
                    <source>

                        <italic toggle="yes">Vitiligo.</italic>
</source>
                    <year>2019</year>;<fpage>333</fpage>&#x2013;<lpage>336</lpage>.
                    <pub-id pub-id-type="doi">10.1007/978-3-319-62960-5_32</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Frisoli</surname>
                            <given-names>ML</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Essien</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Harris</surname>
                            <given-names>JE</given-names>
                        </name>
</person-group>:
                    <article-title>Vitiligo: mechanisms of pathogenesis and treatment.</article-title>
                    <source>

                        <italic toggle="yes">Annu. Rev. Immunol.</italic>
</source>
                    <year>2020</year>;<volume>38</volume>(<issue>1</issue>):<fpage>621</fpage>&#x2013;<lpage>648</lpage>.
                    <pub-id pub-id-type="doi">10.1146/annurev-immunol-100919-023531</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Li</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Li</surname>
                            <given-names>C</given-names>
                        </name>
</person-group>:
                    <article-title>Perspective of new advances in the pathogenesis of vitiligo: from oxidatve stress to autoimmunity.</article-title>
                    <source>

                        <italic toggle="yes">Med. Science Monit.</italic>
</source>
                    <year>2019</year>;<volume>25</volume>:<fpage>1017</fpage>&#x2013;<lpage>1023</lpage>.
                    <pub-id pub-id-type="pmid">30723188</pub-id>
                    <pub-id pub-id-type="doi">10.12659/MSM.914898</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6373225</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Picardo</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>Pathophysiology overview.</article-title>
                    <source>

                        <italic toggle="yes">Vitiligo.</italic>
</source>
                    <year>2019</year>;<fpage>189</fpage>&#x2013;<lpage>192</lpage>.
                    <pub-id pub-id-type="doi">10.1007/978-3-319-62960-5_20</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <label>10</label>
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bergqvist</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ezzdine</surname>
                            <given-names>K</given-names>
                        </name>
</person-group>:
                    <article-title>Vitiligo: a review. Review Article of Dermatology.</article-title>
                    <year>2020</year>;<fpage>1</fpage>&#x2013;<lpage>22</lpage>.
                    <pub-id pub-id-type="doi">10.1159/000506103</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Jadeja</surname>
                            <given-names>SD</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mayatra</surname>
                            <given-names>JM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vaishnav</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A concise review on the role of endoplasmic reticulum stress in the development of autoimmunity in vitiligo pathogenesis.</article-title>
                    <source>

                        <italic toggle="yes">Front. Immunol.</italic>
</source>
                    <year>2021</year>;<volume>11</volume>:<fpage>624566</fpage>.
                    <pub-id pub-id-type="pmid">33613564</pub-id>
                    <pub-id pub-id-type="doi">10.3389/fimmu.2020.624566</pub-id>
                    <pub-id pub-id-type="pmcid">PMC7890234</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Martelli</surname>
                            <given-names>AM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Paganelli</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chiarini</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The unfolded protein response: a novel therapeutic target in acute leukemias.</article-title>
                    <source>

                        <italic toggle="yes">Cancers.</italic>
</source>
                    <year>2020</year>;<volume>12</volume>(<issue>2</issue>):<fpage>333</fpage>.
                    <pub-id pub-id-type="pmid">32024211</pub-id>
                    <pub-id pub-id-type="doi">10.3390/cancers12020333</pub-id>
                    <pub-id pub-id-type="pmcid">PMC7072709</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Siwecka</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rozp&#x0119;dek</surname>
                            <given-names>W</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pytel</surname>
                            <given-names>D</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Dual role of endoplasmic reticulum stress-mediated unfolded protein response signaling pathway in carcinogenesis.</article-title>
                    <source>

                        <italic toggle="yes">Int. J. Mol. Sci.</italic>
</source>
                    <year>2019</year>;<volume>20</volume>(<issue>18</issue>):<fpage>4354</fpage>.
                    <pub-id pub-id-type="pmid">31491919</pub-id>
                    <pub-id pub-id-type="doi">10.3390/ijms20184354</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6770252</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hetz</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhang</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kaufman</surname>
                            <given-names>RJ</given-names>
                        </name>
</person-group>:
                    <article-title>Mechanisms, regulation and functions of the unfolded protein response.</article-title>
                    <source>

                        <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic>
</source>
                    <year>2020</year>;<volume>21</volume>:<fpage>421</fpage>&#x2013;<lpage>438</lpage>.
                    <pub-id pub-id-type="pmid">32457508</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41580-020-0250-z</pub-id>
                    <pub-id pub-id-type="pmcid">PMC8867924</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref15">
                <label>15</label>
                <mixed-citation publication-type="data">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Setyanto</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kalim</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Poeranto</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <data-title>Comparison of BiP and HSP70i as markers of unfolded protein response (UPR) in segmental and nonsegmental vitiligo.</data-title>[Dataset].
                    <source>

                        <italic toggle="yes">Zenodo.</italic>
</source>
                    <year>2022</year>.
                    <pub-id pub-id-type="doi">10.5281/zenodo.7228247</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Park</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lee</surname>
                            <given-names>SE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Shin</surname>
                            <given-names>K-O</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Insights into the role of endoplasmic reticulum stress in skin function and assciated diseases. Review Article.</article-title>
                    <source>

                        <italic toggle="yes">FEBS J.</italic>
</source>
                    <year>2019</year>;<volume>286</volume>:<fpage>413</fpage>&#x2013;<lpage>425</lpage>.
                    <pub-id pub-id-type="pmid">30586218</pub-id>
                    <pub-id pub-id-type="doi">10.1111/febs.1473</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6362265</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kundu</surname>
                            <given-names>RV</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mhlaba</surname>
                            <given-names>JM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rangel</surname>
                            <given-names>SM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The convergence theory for vitiligo: A reappraisal.</article-title>
                    <source>

                        <italic toggle="yes">Exp. Dermatol.</italic>
</source>
                    <year>2018</year>;<volume>28</volume>:<fpage>647</fpage>&#x2013;<lpage>655</lpage>.
                    <pub-id pub-id-type="pmid">29704874</pub-id>
                    <pub-id pub-id-type="doi">10.1111/exd.13677</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6204319</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref18">
                <label>18</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>X</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Guo</surname>
                            <given-names>W</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chang</surname>
                            <given-names>Y</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo.</article-title>
                    <source>

                        <italic toggle="yes">Free Radic. Biol. Med.</italic>
</source>
                    <year>2019</year>;<volume>139</volume>:<fpage>80</fpage>&#x2013;<lpage>91</lpage>.
                    <pub-id pub-id-type="pmid">31078730</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2019.05.011</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref19">
                <label>19</label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Abbas</surname>
                            <given-names>AK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lichtman</surname>
                            <given-names>AH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pillai</surname>
                            <given-names>S</given-names>
                        </name>
</person-group>:
                    <source>

                        <italic toggle="yes">Cellular and molecular immunology.</italic>
</source>
                    <edition>9th ed.</edition>
                    <publisher-loc>Winsland</publisher-loc>:
                    <publisher-name>Elsevier</publisher-name>.</mixed-citation>
            </ref>
            <ref id="ref20">
                <label>20</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tang</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Li</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fu</surname>
                            <given-names>W</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo.</article-title>
                    <source>

                        <italic toggle="yes">Aging.</italic>
</source>
                    <year>2019</year>;<volume>11</volume>(<issue>24</issue>):<fpage>11829</fpage>&#x2013;<lpage>11843</lpage>.
                    <pub-id pub-id-type="pmid">31866583</pub-id>
                    <pub-id pub-id-type="doi">10.18632/aging.102452</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6949104</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref21">
                <label>21</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Singh</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kotnis</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jadeja</surname>
                            <given-names>SD</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Cytokines: the yin and yang of vitiligo pathogenesis.</article-title>
                    <source>

                        <italic toggle="yes">Expert. Rev. Clin. Immunol.</italic>
</source>
                    <year>2018</year>;<volume>15</volume>:<fpage>177</fpage>&#x2013;<lpage>188</lpage>.
                    <pub-id pub-id-type="pmid">30462555</pub-id>
                    <pub-id pub-id-type="doi">10.1080/1744666x.2019.1550358</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref22">
                <label>22</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mathachan</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Khurana</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gautam</surname>
                            <given-names>R</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Does oxidative stress correlate with disease activity and severity in vitiligo? An analytical study.</article-title>
                    <source>

                        <italic toggle="yes">J. Cosmet. Dermatol.</italic>
</source>
                    <year>2020</year>;<volume>20</volume>:<fpage>352</fpage>&#x2013;<lpage>359</lpage>.
                    <pub-id pub-id-type="pmid">32422682</pub-id>
                    <pub-id pub-id-type="doi">10.1111/jocd.13499</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref23">
                <label>23</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Manga</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Elbuluk</surname>
                            <given-names>OSJ</given-names>
                        </name>
</person-group>:
                    <article-title>Recent advances in understanding vitiligo.</article-title>
                    <source>

                        <italic toggle="yes">F1000 Res.</italic>
</source>
                    <year>2016</year>;<volume>5</volume>:<fpage>2234</fpage>.
                    <pub-id pub-id-type="pmid">27635239</pub-id>
                    <pub-id pub-id-type="doi">10.12688/f1000research.8976.1</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5017284</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref24">
                <label>24</label>
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bakry</surname>
                            <given-names>O</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Elhefnawy</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Seliet</surname>
                            <given-names>E</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Determination of oxidative stress in vitiligo by measuring superoxide dismutase levels in vitiliginous skin. Original Article.</article-title>
                    <year>2020</year>;<volume>33</volume>(<issue>1</issue>):<fpage>262</fpage>&#x2013;<lpage>266</lpage>.
                    <pub-id pub-id-type="doi">10.4103/mmj.mmj_246_18</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref25">
                <label>25</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Smith</surname>
                            <given-names>JA</given-names>
                        </name>
</person-group>:
                    <article-title>Regulation of cytokine production by the unfolded protein response; implications for infection and autoimmunity.</article-title>
                    <source>

                        <italic toggle="yes">Front. Immunol.</italic>
</source>
                    <year>2018</year>;<volume>9</volume>:<fpage>9</fpage>.
                    <pub-id pub-id-type="pmid">29556237</pub-id>
                    <pub-id pub-id-type="doi">10.3389/fimmu.2018.00422</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5844972</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref26">
                <label>26</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sarma</surname>
                            <given-names>N</given-names>
                        </name>
</person-group>:
                    <article-title>Nonsegmental vitiligo follows Blaschko's lines and embryonic pigmentary segments.</article-title>
                    <source>

                        <italic toggle="yes">Indian J. Dermatol. Venereol. Leprol.</italic>
</source>
                    <year>2020</year>;<volume>86</volume>(<issue>4</issue>):<fpage>350</fpage>&#x2013;<lpage>358</lpage>.
                    <pub-id pub-id-type="pmid">31898641</pub-id>
                    <pub-id pub-id-type="doi">10.4103/ijdvl.IJDVL_790_18</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref27">
                <label>27</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Khaitan</surname>
                            <given-names>BK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sindhuja</surname>
                            <given-names>T</given-names>
                        </name>
</person-group>:
                    <article-title>Autoimmunity in vitiligo: Therapeutic implications and opportunities.</article-title>
                    <source>

                        <italic toggle="yes">Autoimmun. Rev.</italic>
</source>
                    <year>2021</year>;<volume>21</volume>:<fpage>102932</fpage>.
                    <pub-id pub-id-type="pmid">34506987</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.autrev.2021.102932</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref28">
                <label>28</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ramirez</surname>
                            <given-names>MU</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hernandez</surname>
                            <given-names>SR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Soto-Pantoja</surname>
                            <given-names>DR</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Endoplasmic reticulum stress pathway, the unfolded protein response, modulates immune function in the tumor microenvironment to impact tumor progression and therapeutic response.</article-title>
                    <source>

                        <italic toggle="yes">Int. J. Mol. Sci.</italic>
</source>
                    <year>2019</year>;<volume>21</volume>(<issue>1</issue>):<fpage>169</fpage>.
                    <pub-id pub-id-type="pmid">31881743</pub-id>
                    <pub-id pub-id-type="doi">10.3390/ijms21010169</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6981480</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref29">
                <label>29</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Shimizu</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kaira</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Yasuda</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Clinical and pathological significance of ER stress marker (BiP/GRP78 and PERK) expression in malignant melanoma.</article-title>
                    <source>

                        <italic toggle="yes">Pathol. Oncol. Res.</italic>
</source>
                    <year>2017</year>;<volume>23</volume>(<issue>1</issue>):<fpage>111</fpage>&#x2013;<lpage>116</lpage>.
                    <pub-id pub-id-type="pmid">27502501</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s12253-016-0099-9</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref30">
                <label>30</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Shi</surname>
                            <given-names>MH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wu</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Li</surname>
                            <given-names>L</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Meta-analysis of the association between vitiligo and the level of superoxide dismutase or malondialdehyde.</article-title>
                    <source>

                        <italic toggle="yes">Clin. Exp. Dermatol.</italic>
</source>
                    <year>2017</year>;<volume>42</volume>(<issue>1</issue>):<fpage>21</fpage>&#x2013;<lpage>29</lpage>.
                    <pub-id pub-id-type="doi">10.1111/ced.12950</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref31">
                <label>31</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Rashighi</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Harris</surname>
                            <given-names>JE</given-names>
                        </name>
</person-group>:
                    <article-title>Vitiligo pathogenesis and emerging treatments.</article-title>
                    <source>

                        <italic toggle="yes">Dermatol. Clin.</italic>
</source>
                    <year>2017</year>;<volume>35</volume>(<issue>2</issue>):<fpage>257</fpage>&#x2013;<lpage>265</lpage>.
                    <pub-id pub-id-type="pmid">28317534</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.det.2016.11.014</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5362109</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref32">
                <label>32</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Malgarin</surname>
                            <given-names>CM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nosach</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Novakovic</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Classification of fetal resilience to porcine reproductive and respiratory syndrome (PRRS) based on temporal viral load in late gestation maternal tissues and fetuses.</article-title>
                    <source>

                        <italic toggle="yes">Virus Res.</italic>
</source>
                    <year>2019</year>;<volume>260</volume>:<fpage>151</fpage>&#x2013;<lpage>162</lpage>.
                    <pub-id pub-id-type="pmid">30529234</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.virusres.2018.12.002</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref33">
                <label>33</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Liu</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Han</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Liu</surname>
                            <given-names>J</given-names>
                        </name>
</person-group>:
                    <article-title>The role of toll-like receptors in oncotherapy.</article-title>
                    <source>

                        <italic toggle="yes">Oncol. Res.</italic>
</source>
                    <year>2019</year>;<volume>27</volume>(<issue>8</issue>):<fpage>965</fpage>&#x2013;<lpage>978</lpage>.
                    <pub-id pub-id-type="pmid">30940297</pub-id>
                    <pub-id pub-id-type="doi">10.3727/096504019x15498329881440</pub-id>
                    <pub-id pub-id-type="pmcid">PMC7848423</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref34">
                <label>34</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ryan</surname>
                            <given-names>GE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Harris</surname>
                            <given-names>JE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Richmond</surname>
                            <given-names>JM</given-names>
                        </name>
</person-group>:
                    <article-title>Resident memory T cells in autoimmune skin diseases.</article-title>
                    <source>

                        <italic toggle="yes">Front. Immunol.</italic>
</source>
                    <year>2021</year>;<volume>12</volume>:<fpage>652191</fpage>.
                    <pub-id pub-id-type="pmid">34012438</pub-id>
                    <pub-id pub-id-type="doi">10.3389/fimmu.2021.6521</pub-id>
                    <pub-id pub-id-type="pmcid">PMC8128248</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref35">
                <label>35</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Abdel-Malek</surname>
                            <given-names>ZA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jordan</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ho</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The enigma and challenges of vitiligo pathophysiology and treatment.</article-title>
                    <source>

                        <italic toggle="yes">Pigment Cell Melanoma Res.</italic>
</source>
                    <year>2020</year>;<volume>33</volume>:<fpage>778</fpage>&#x2013;<lpage>787</lpage>.
                    <pub-id pub-id-type="pmid">32198977</pub-id>
                    <pub-id pub-id-type="doi">10.1111/pcmr.12878</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref36">
                <label>36</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Xie</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhou</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Liu</surname>
                            <given-names>L</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Vitiligo: How do oxidative strss-induced autoantigens triger autoimmunity?</article-title>
                    <source>

                        <italic toggle="yes">J. Dermatol. Sci.</italic>
</source>
                    <year>2016</year>;<volume>81</volume>(<issue>1</issue>):<fpage>3</fpage>&#x2013;<lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">26387449</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jdermsci.2015.09.003</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref37">
                <label>37</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sherif</surname>
                            <given-names>AS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Enas</surname>
                            <given-names>T</given-names>
                        </name>
</person-group>:
                    <article-title>Understanding the role of lymphocytes in vitiligo.</article-title>
                    <source>

                        <italic toggle="yes">Int. J. Immunol. Immunother.</italic>
</source>
                    <year>2021</year>;<volume>8</volume>:<fpage>060</fpage>.
                    <pub-id pub-id-type="doi">doi.org/10.23937/2378-3672/1410060</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref38">
                <label>38</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ruiz-Arg&#x00fc;elles</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Brito</surname>
                            <given-names>GJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Reyes-Izquierdo</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Apoptosis of melanocytes in vitiligo results from antibody penetration.</article-title>
                    <source>

                        <italic toggle="yes">J. Autoimmun.</italic>
</source>
                    <year>2017</year>;<volume>29</volume>(<issue>4</issue>):<fpage>281</fpage>&#x2013;<lpage>286</lpage>.
                    <pub-id pub-id-type="pmid">17888626</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jaut.2007.07.012</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref39">
                <label>39</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Riding</surname>
                            <given-names>RL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Harris</surname>
                            <given-names>JE</given-names>
                        </name>
</person-group>:
                    <article-title>The role of memory CD8+ T cells in vitiligo.</article-title>
                    <source>

                        <italic toggle="yes">J. Immunol.</italic>
</source>
                    <year>2019</year>;<volume>203</volume>(<issue>1</issue>):<fpage>11</fpage>&#x2013;<lpage>19</lpage>.
                    <pub-id pub-id-type="pmid">31209143</pub-id>
                    <pub-id pub-id-type="doi">10.4049/jimmunol.1900027</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6709670</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref40">
                <label>40</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Arora</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kumaran</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>Pathogenesis of vitiligo: An update.</article-title>
                    <source>

                        <italic toggle="yes">Pigment Int.</italic>
</source>
                    <year>2017</year>;<volume>4</volume>(<issue>2</issue>):<fpage>65</fpage>.
                    <pub-id pub-id-type="doi">10.4103/2349-5847.219673</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report198869">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.138473.r198869</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Inoue</surname>
                        <given-names>Shintaro</given-names>
                    </name>
                    <xref ref-type="aff" rid="r198869a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-4996-5693</uri>
                </contrib>
                <aff id="r198869a1">
                    <label>1</label>Department of Cosmetic Health Science, Gifu Pharmaceutical University, Gifu, Japan</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>20</day>
                <month>9</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Inoue S</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport198869" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.126096.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The authors compared the usefulness of two markers (BiP and HSP70i) in SV and NSV and concluded that HSP70i is superior to BiP for assessing UPR.&#x00a0;However, there is insufficient evidence to draw the authors' conclusions for the following reasons: 
                <list list-type="order">
                    <list-item>
                        <p>The Bip (rabbit polyclonal) and HSP70i (mouse monoclonal) antibodies have different reactivity and chromogenicity toward their respective proteins. Even in the same skin sample, you cannot compare the expression levels of Bip and HSP70i proteins by their chromogenic intensity. You can only compare the fluorescence intensity between lesional and non-lesional areas of the same patient using the same antibody, or between SV and NSV stained simultaneously using the same antibody.</p>
                    </list-item>
                    <list-item>
                        <p>To consider the significance of Bip and HSP70i in vitiligo pathogenesis, it is desirable to show differences in signal intensity between lesional and non-lesional areas in SV and NSV, respectively.</p>
                    </list-item>
                    <list-item>
                        <p>I am unable to see the quantitative data that should be shown in Fig. 1a and Fig. 2a.</p>
                    </list-item>
                    <list-item>
                        <p>97% of NSV and 55% of SV patients receive topical steroid treatment. At the very least, I would like to see verification that there is no difference in staining intensity of Bip and HSP70i when SV patients are divided into groups with and without topical steroids.&#x00a0;If possible, it would be nice to have data on patients with NSV who have not received topical steroid therapy in the months prior to the study.</p>
                    </list-item>
                    <list-item>
                        <p>There is no information on the stage of disease (stable, progressive, etc.) or the analysis sites (lesion, perilesional, non-lesion) used in the analysis, nor is there any information on the sites of selection or selection criteria for the analyses.</p>
                    </list-item>
                    <list-item>
                        <p>In NSV, extracellular secretion of HSP70i is important for dendritic cell activation. It would be interesting to have a comparison of fluorescence intensity of extracellular HSP70i limited to just below the basement membrane.</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Partly</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>I cannot comment. A qualified statistician is required.</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Partly</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>No</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>No</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>No</p>
            <p>Reviewer Expertise:</p>
            <p>Cell biology and biochemistry (vitiligo pathophysiology, tight junction barrier regulation, and regulation of hyaluronan metabolism in the skin)</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report191022">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.138473.r191022</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Dwivedi</surname>
                        <given-names>Mitesh</given-names>
                    </name>
                    <xref ref-type="aff" rid="r191022a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-8497-0765</uri>
                </contrib>
                <aff id="r191022a1">
                    <label>1</label>C. G. Bhakta Institute of Biotechnology, Uka Tarsadia University, Bardoli, Gujarat, India</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>15</day>
                <month>8</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Dwivedi M</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport191022" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.126096.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The authors have investigated the UPR-BiP and UPR-HSP70i markers through their expression in the skin of vitiligo patients and established a correlation. The study seems interesting as it has been done for the first time by comparing these markers in two types of vitiligo. However, the study needs more clarification for few concerns raised here and includes few analyses as suggested to improve the study and its presentation. 
                <list list-type="order">
                    <list-item>
                        <p>I suggest authors to improve introduction section. Authors must cite additional studies to back up their rationale for the study.</p>
                    </list-item>
                    <list-item>
                        <p>How did authors calculate the sample size? Sample size calculation must be mentioned in the methods section.</p>
                    </list-item>
                    <list-item>
                        <p>In the skin biopsy section, authors mention that perilesional skin sample was acquired from the study subjects. Why didn&#x2019;t author choose lesional skin for the experiments?</p>
                    </list-item>
                    <list-item>
                        <p>Although authors have seen
                            <bold> </bold>the expression of the UPR marker in skin biopsy and then an immunofluorescence examination to identify expression of BiP and HSP70i. But solely observing expression within skin section would not be enough to make any conclusion. I advise authors to also seek out for ROS mediated damage within the skin samples. Therefore, I recommend authors to include oxidative stress marker H
                            <sub>2</sub>O
                            <sub>2</sub> levels within the skin samples.</p>
                    </list-item>
                    <list-item>
                        <p>It is difficult to understand Figure 2(a). I would advise authors to elaborate what they exactly mean by the figure in detail within legends.</p>
                    </list-item>
                    <list-item>
                        <p>UPR pathway is activated when there is decline in calcium concentration in the endoplasmic reticulum which also contributes in the unfolded/misfolded proteins. Authors could have also look for calcium levels within the patients. Consequently, authors can cite recent studies done on calcium and calcium related effects in vitiligo
                            <sup>
                                <xref ref-type="bibr" rid="rep-ref-191022-1">1</xref>
                            </sup>
                            <sup>-</sup>
                            <sup>
                                <xref ref-type="bibr" rid="rep-ref-191022-4">4</xref>
                            </sup>.</p>
                    </list-item>
                    <list-item>
                        <p>Why didn&#x2019;t authors see expression levels of endoplasmic reticulum sensor proteins such as ATF, IRE, PERK, etc.?</p>
                    </list-item>
                    <list-item>
                        <p>HSP-70i and BiP could also play a role in the immunological mechanism leading to vitiligo through activation of lymphocytes and macrophages, activation and maturation of dendritic cells as an antigen presenting cells and initiating the release of cytokines. It would be interesting to evaluate the production of TNF-&#x03b1;, IL-1&#x03b2;, IL-12, and IL-6 within skin samples because they are apoptosis mediators and inhibitor of melanogenesis leading to vitiligo.</p>
                    </list-item>
                    <list-item>
                        <p>In addition, authors could also look for inflammatory cytokines such as IFN-gamma, IL-17 in order to relate its relation with ROS production.</p>
                    </list-item>
                    <list-item>
                        <p>Moreover, authors must carry out correlation analysis for expression of HSP-70i and BiP with the disease activity and vitiligo patients.</p>
                    </list-item>
                    <list-item>
                        <p>Abstract: Please remove (&lt;&#x03b1; = 0.05) from results section.</p>
                    </list-item>
                    <list-item>
                        <p>Please check the sentence formation and grammatical errors throughout the manuscript: "UPR expression using the HSP70i marker in both NSV and SV groups was higher than it was using the BiP marker."</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Yes</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Yes</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Autoimmunity; Immunogenetics; Skin Immunity</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <back>
            <ref-list>
                <title>References</title>
                <ref id="rep-ref-191022-1">
                    <label>1</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients.</article-title>
                        <source>
                            <italic>Immunology</italic>
                        </source>.<year>2022</year>;<volume>167</volume>(<issue>3</issue>) :
                        <elocation-id>10.1111/imm.13538</elocation-id>
                        <fpage>314</fpage>-<lpage>327</lpage>
                        <pub-id pub-id-type="pmid">35754117</pub-id>
                        <pub-id pub-id-type="doi">10.1111/imm.13538</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-191022-2">
                    <label>2</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>The Evaluation of Vitiligous lesions Repigmentation after the Administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo (EVRAAS), a pilot study: study protocol for a randomized controlled trial.</article-title>
                        <source>
                            <italic>Trials</italic>
                        </source>.<year>2019</year>;<volume>20</volume>(<issue>1</issue>) :
                        <elocation-id>10.1186/s13063-018-3168-4</elocation-id>
                        <fpage>78</fpage>
                        <pub-id pub-id-type="pmid">30683146</pub-id>
                        <pub-id pub-id-type="doi">10.1186/s13063-018-3168-4</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-191022-3">
                    <label>3</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>[Ultrastructural changes of epidermal calcium gradient and lipid lamellar membrane in depigmented skin lesions of vitiligo patients].</article-title>
                        <source>
                            <italic>Zhonghua Yi Xue Za Zhi</italic>
                        </source>.<year>2016</year>;<volume>96</volume>(<issue>14</issue>) :
                        <elocation-id>10.3760/cma.j.issn.0376-2491.2016.14.009</elocation-id>
                        <fpage>1108</fpage>-<lpage>11</lpage>
                        <pub-id pub-id-type="pmid">27095778</pub-id>
                        <pub-id pub-id-type="doi">10.3760/cma.j.issn.0376-2491.2016.14.009</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-191022-4">
                    <label>4</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients.</article-title>
                        <source>
                            <italic>Dermatology</italic>
                        </source>.<year>1995</year>;<volume>190</volume>(<issue>3</issue>) :
                        <elocation-id>10.1159/000246690</elocation-id>
                        <fpage>223</fpage>-<lpage>9</lpage>
                        <pub-id pub-id-type="pmid">7599386</pub-id>
                        <pub-id pub-id-type="doi">10.1159/000246690</pub-id>
                    </mixed-citation>
                </ref>
            </ref-list>
        </back>
    </sub-article>
</article>
